madman
Super Moderator
Conclusion:
- among men with low testosterone and normal PSA levels who were followed for a median of 3 years, compared with untreated men, men treated with testosterone were not at increased risk of incident aggressive or any prostate cancer
- the longer term clinical risks and benefits of testosterone treatment can only be definitively addressed by large, long-term randomized controlled trials
http://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0199194&type=printable
- among men with low testosterone and normal PSA levels who were followed for a median of 3 years, compared with untreated men, men treated with testosterone were not at increased risk of incident aggressive or any prostate cancer
- the longer term clinical risks and benefits of testosterone treatment can only be definitively addressed by large, long-term randomized controlled trials
http://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0199194&type=printable